Pharma Mar | PHM - Ebit

Stock Price
77.60
Daily Change
1.00 1.31%
Monthly
3.60%
Yearly
-15.28%
Q1 Forecast
76.83

Pharma Mar reported EUR-3.96M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
Alaunos Therapeutics USD -1.19M 148K Sep/2025
Almirall EUR 43.02M 28.78M Jun/2025
Avita Medical AUD -8.66M 1.61M Jun/2025
Dianthus Therapeutics USD -40.29M 5.36M Sep/2025
Ionis Pharmaceuticals USD -160.18M 304.96M Sep/2025
IQVIA Holdings USD 573M 17M Sep/2025
Laboratorios Farma EUR 135.05M 49.84M Dec/2023
Moderna USD -260M 557M Sep/2025
Organon & Co USD 388M 28M Sep/2025
Pharma Mar EUR -3.96M 28.11M Sep/2025
Revvity USD 98.34M 7.58M Sep/2025
Tectonic Therapeutic USD -22.33M 4.03M Jun/2025
Viatris USD 234.5M 49.1M Sep/2025
Xeris Pharmaceuticals USD 7.89M 2.46M Sep/2025